Diamonds and Dogs


Kraft Heinz (KHC) higher on a surge in demand. The consumer staple is up 4% to a one month high after reporting better-than-expected sales growth due to the coronavirus. The company now expects 3% sales growth in the first quarter. That is about $200 million, or 3.7%, better than Wall Street was modeling. Restaurant sales have taken a hit which account for 15% of Heinz's business.

Gilead (GILD) taking a hit. Skepticism is growing regarding Gilead's drug remdesivir to fight the coronavirus. Data from two Chinese trials are expected in the coming weeks. With a potential vaccine more than a year away, Gilead's antiviral remdesivir offers one of the nearest-term hopes for a treatment in the pandemic. The analyst over at Barclays believes the risk/reward is not in favor of a positive result for Gilead.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.